We are live on
!
Find out more
DIM
DC Investments Management Portfolio holdings
AUM
$261M
1-Year Est. Return
20.71%
This Fund
S&P 500
This Quarter
Est. Return
+3.69%
1 Year Est. Return
+20.71%
3 Year Est. Return
+44.71%
5 Year Est. Return
+36.74%
10 Year Est. Return
–
AUM
$157M
AUM Growth
+$8.18M
(+5.5%)
Cap. Flow
+$6.12M
Cap. Flow
% of AUM
3.89%
Top 10 Holdings %
Top 10 Hldgs %
6.71%
Holding
424
New
174
Increased
42
Reduced
68
Closed
139
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Evergy
EVRG
|
+$1.09M |
| 2 |
AerCap
AER
|
+$863K |
| 3 |
GRMN
Garmin
GRMN
|
+$838K |
| 4 |
GSK
GSK
|
+$820K |
| 5 |
SF
Stifel
SF
|
+$818K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$2.51M |
| 2 |
Amgen
AMGN
|
+$2.11M |
| 3 |
Johnson & Johnson
JNJ
|
+$1.68M |
| 4 |
Northrop Grumman
NOC
|
+$1.55M |
| 5 |
Becton Dickinson
BDX
|
+$1.52M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.87% |
| 2 | Financials | 19.67% |
| 3 | Technology | 12.25% |
| 4 | Real Estate | 10.82% |
| 5 | Utilities | 10.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
W.R. Berkley
WRB
$26.7B
| $524K | 0.33% |
24,432
+10,459
| +75% | +$233K |
|
177
Amdocs
DOX
$5.85B
| $523K | 0.33% |
7,896
-13,741
| -64% | -$925K |
|
178
Procter & Gamble
PG
$341B
| $523K | 0.33% |
6,702
-4,587
| -41% | -$345K |
|
|
TSS
179
DELISTED
Total System Services, Inc.
TSS
| $523K | 0.33% |
+6,192
| New | +$533K |
|
180
DTE Energy
DTE
$29B
| $522K | 0.33% |
5,920
-5,110
| -46% | -$443K |
|
181
Consolidated Edison
ED
$39.7B
| $522K | 0.33% |
6,700
-5,625
| -46% | -$430K |
|
182
Hawaiian Electric Industries
HE
$2.17B
| $519K | 0.33% |
15,136
-16,028
| -51% | -$545K |
|
|
LOVE
183
LoveSac
LOVE
$270M
| $519K | 0.33% |
+25,010
| New | +$551K |
|
|
NWLI
184
DELISTED
National Western Life Group, Inc. Class A
NWLI
| $518K | 0.33% |
+1,686
| New | +$526K |
|
185
AGNC Investment
AGNC
$12.6B
| $516K | 0.33% |
27,763
+12,888
| +87% | +$243K |
|
186
FS KKR Capital
FSK
$3.06B
| $516K | 0.33% |
+17,555
| New | +$536K |
|
187
Annaly Capital Management
NLY
$17B
| $516K | 0.33% |
+12,527
| New | +$522K |
|
188
US Bancorp
USB
$100B
| $516K | 0.33% |
+10,308
| New | +$523K |
|
189
Revvity
RVTY
$12.8B
| $515K | 0.33% |
7,034
+3,255
| +86% | +$244K |
|
190
John Wiley & Sons Class A
WLY
$2.75B
| $514K | 0.33% |
+8,238
| New | +$547K |
|
|
CIT
191
DELISTED
CIT Group Inc.
CIT
| $514K | 0.33% |
+10,200
| New | +$532K |
|
192
Tyson Foods
TSN
$20.5B
| $513K | 0.33% |
+7,446
| New | +$518K |
|
|
PBCT
193
DELISTED
People's United Financial Inc
PBCT
| $513K | 0.33% |
+28,350
| New | +$527K |
|
194
Silgan Holdings
SLGN
$4.49B
| $512K | 0.33% |
+19,074
| New | +$524K |
|
195
Marathon Petroleum
MPC
$88.1B
| $511K | 0.33% |
+7,278
| New | +$556K |
|
196
Graham Holdings Company
GHC
$5.09B
| $510K | 0.32% |
+870
| New | +$522K |
|
197
Waters Corp
WAT
$39B
| $510K | 0.32% |
2,632
+108
| +4% | +$21.3K |
|
198
Conagra Brands
CAG
$7.13B
| $509K | 0.32% |
+14,238
| New | +$530K |
|
199
Eastman Chemical
EMN
$8.38B
| $509K | 0.32% |
+5,088
| New | +$537K |
|
200
Kimberly-Clark
KMB
$37.1B
| $509K | 0.32% |
+4,836
| New | +$502K |
|
Similar funds
DC
AFC
TIG
NG
ICM
TSW
ACM
ASP
DC Investments Management's Q2 2018 Portfolio in Review
As of Q2 2018, DC Investments Management held 424 positions worth $157M, up 5.5% from $149M the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.
DC Investments Management deployed $6.12M of net new capital in Q2 2018, opening 174 new positions and adding to 42 existing holdings. Its largest new stake was Evergy: 20,319 shares worth $1.14M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 23% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Pfizer, an estimated $2.51M trimmed.
- DC Investments Management's largest Q2 2018 buy was Evergy: 20,319 shares worth $1.14M.
- DC Investments Management added most to TotalEnergies in Q2 2018, an estimated $612K increase.
- DC Investments Management's biggest Q2 2018 reduction was Pfizer, cutting an estimated $2.51M.
- DC Investments Management fully exited Amgen in Q2 2018, selling an estimated $2.11M.
- DC Investments Management's ten largest holdings make up 6.7% of its $157M portfolio in Q2 2018.
- DC Investments Management opened 174 new positions and closed 139 in Q2 2018.
- DC Investments Management's portfolio value rose 5.5% quarter-over-quarter to $157M.
Based on DC Investments Management's 13F filing for Q2 2018, filed 3 Aug 2018.